Advancing the Science

Mayo Clinic Medical Science Blog – an eclectic collection of research- and research education-related stories: feature stories, mini news bites, learning opportunities, profiles and more from Mayo Clinic.

Items Tagged ‘marijuana’

July 14, 2021 · Leave a Comment

Mayo Clinic research in the news — 7/12/2021

By Advancing the Science contributor Advancing the Science contributor (@advancingthescience)

Research and expertise from Mayo Clinic have been in the news on topics from marijuana, sleep, disparities, dementia and doses of vaccine. Read more. New York Times, Can Marijuana Make You a Better Athlete?  … “If you look at any test of physical performance, there’s either no data, it’s a wash, or marijuana makes it worse,” […]

View full entry Comment on this

Tags: addiction research, alcoholism, Alejandro Rabinstein, Alyx Porter, Alzheimer's disease, artificial intelligence, autoimmune disorder, Bhanu Kolla, breast cancer, cancer vaccine, cardiology, Center for Individualized Medicine


March 8, 2021 · Leave a Comment

Mayo Clinic Research in the news — 3/8/2021

By Advancing the Science contributor Advancing the Science contributor (@advancingthescience)

In Mayo Clinic research news over the past seven days, the headlines covered medical marijuana, systemic racism, Alzheimer’s, and a range of other topics including COVID-19. Minnesota Senate bill could increase spinal cord research funding, KSTP, 3/4/2021 This $285 eye scan may someday detect Alzheimer’s risk. (It also requires plenty of curry flavoring.), Advisory Board, […]

View full entry Comment on this

Tags: ADHD, aging, Alzheimer's disease, biomarkers, cholesterol, clinical trials, colorectal cancer, COVID-19, dementia, health care systems engineering, health disparities, lymphoma


October 26, 2020 · Leave a Comment

Mayo Clinic Research in the news — 10/26/2020

By Elizabeth Zimmermann Elizabeth Zimmermann (@elizabethzimmermann)

At Mayo Clinic, patient care is evidence-based, meaning research drives the practice of medicine. Our scientists and clinician researchers are at work across the spectrum of health and the delivery of health care, seeking better outcomes and enhanced experiences while managing the total costs of care. Curable dementia, pot and opioids, childcare during COVID-19, and […]

View full entry Comment on this

Tags: Alzheimer's disease, Andrew Badley, artificial intelligence, autoimmune disorder, biomarkers, cardiovascular medicine, Charles Adler, clinical research, clinical trials, COVID-19, David Knopman, dementia


Contact Us · Privacy Policy